Strategic Advisory Services

Senior ABPI Compliance Counsel for the Decisions That Cannot Afford to Be Wrong

PMCPA complaints, product launches, inspection preparation, novel activity structures, board-level briefings. Compliance advice that tells you not just whether something is permissible — but how to structure it so it works commercially as well as legally.

Request a Consultation →
ABPI Registered Final Signatory with deep Code 2024 expertise
Strategic Commercial as well as compliant — structures that work for your business
PMCPA Complaint response, mock audits, and inspection readiness
Flexible Retained, project-based, or ad hoc — scoped to your situation

High-Stakes Compliance Decisions Require More Than a Code Reference

Standard compliance guidance tells you what the rules say. Strategic advisory tells you how to navigate a specific situation — factoring in the commercial objective, the regulatory context, precedent from PMCPA case outcomes, and the risk profile of the specific structure being considered.

A PMCPA complaint has arrived and your team does not know how to respond without making it worse

The way a company responds to a PMCPA complaint — the speed, tone, framing, and completeness of the response — materially affects the outcome. An uncoordinated response that volunteers additional information or mischaracterises the activity under complaint can convert a manageable situation into a formal breach finding.

A product launch is eight weeks away and the promotional concept has no precedent in your organisation

Novel promotional approaches — interactive digital tools, patient-directed content, combined HCP and patient campaigns, social media strategies — create compliance questions that internal teams have never had to answer before. The pressure of a launch timeline does not leave room for iterative learning.

A new patient engagement programme needs board-level compliance sign-off

Patient organisation interactions, disease awareness campaigns, and patient support programmes each carry specific Code obligations that are distinct from standard HCP promotional activity. Board-level stakeholders need clear, confident advice — not a list of rules to read.

A digital campaign has been structured in a way that creates Code exposure nobody in the commercial team has spotted

Digital channels move fast and compliance scrutiny often follows behind. Campaigns that are well-intentioned can carry structural issues — signposting failures, missing fair balance, promotional/non-promotional boundary breaches — that are not visible until an independent expert reviews the full structure.

An MHRA or ABPI inspection is approaching and leadership wants a compliance MOT first

Inspections reward documented processes, clear governance, and the ability to demonstrate compliant decision-making retrospectively. A gap analysis and mock audit before the real thing allows time to address weaknesses rather than explain them.

No internal function with the seniority or expertise to advise on novel compliance questions

Many UK affiliates operate without a dedicated in-house compliance officer at the level required to advise on genuinely complex questions. External strategic advisory provides that expertise on a flexible basis — without the cost of a permanent hire.

Senior Counsel Across the Full Scope of ABPI Compliance Challenges

Strategic advisory engagements are structured around the specific situation. The six areas below cover the most common advisory contexts — all are available as retained, project-based, or ad hoc engagements.

Complaint response

PMCPA Complaint Management

From initial receipt through to written response submission. Material review, response strategy, case framing, and ongoing PMCPA liaison. Also available for pre-emptive complaint risk assessment where a complaint is anticipated.

Launch strategy

Pre-Launch Compliance Review

Structural review of the planned promotional approach before any material enters the review cycle. Identifies Code exposure in campaign architecture, channel selection, and activity classification — before the cost of rework is at its highest.

Inspection readiness

Audit Preparation & Mock Audit

Pre-inspection gap analysis, mock audit against ABPI and MHRA expectations, and a prioritised written report of findings. Ensures the organisation can demonstrate compliant decision-making with appropriate documentation before the inspection date.

Novel activities

Novel Activity Structure Advice

Patient organisation interactions, disease awareness programmes, NIS studies, named patient schemes, and cross-border campaigns — each with specific Code obligations. Strategic advice on how to structure the activity to achieve the commercial objective within compliant boundaries.

Digital compliance

Digital Campaign Compliance Review

Independent review of the structure, content, and channel strategy for digital campaigns, including social media, paid search, influencer-adjacent content, and interactive digital tools. Focus on structural Code compliance — not just claims review.

Retained counsel

Retained Strategic Advisory

Ongoing senior compliance counsel on a retained basis — available for queries, reviews, and escalations as they arise. Provides continuity of expertise for organisations that need reliable compliance advice without the cost structure of a senior in-house hire.

From First Call to Resolved — How a PMCPA Complaint Engagement Works

PMCPA complaint management follows a defined process. The way each stage is handled determines the outcome. Speed, accuracy, and strategic framing of the response are all within your control — with the right advice from the outset.

1

Initial briefing and material review

Review of the complaint, all materials under complaint, and relevant internal records. Initial assessment of the strength of the complaint and the likely PMCPA response approach.

2

Response strategy development

Framing of the company's response — what to address directly, what context to provide, and what to avoid volunteering. Strategy aligned with PMCPA procedural requirements and precedent from comparable case outcomes.

3

Written response preparation

Drafting and review of the formal written response to the PMCPA. Every response is reviewed for completeness, tone, and strategic framing before submission.

4

Ongoing case management

Support through subsequent PMCPA correspondence, panel hearings where required, and any undertaking or remedial action process. Available for the full duration of the case.

5

Portfolio risk review

Following complaint resolution, a review of current materials and activities for similar issues — preventing a resolved complaint from generating a second one from a different complainant.

Named Patient & Early Access Programmes

How to structure named patient and early access activities without creating promotional material or crossing the boundary into unlicensed promotion.

Patient Organisation Interactions

Funding, collaboration, and joint working — ensuring patient organisation relationships meet the specific Code requirements for transparency, independence, and documentation.

Non-Interventional Studies (NIS)

Design and conduct of NIS in compliance with Chapter 21 — including protocol review, HCP engagement structures, and the boundary with promotional activity.

Cross-Border Digital Activities

Digital content accessible across multiple markets — ABPI Code jurisdiction questions, country of origin principles, and platform-specific compliance requirements.

Board & Leadership Briefings

Clear, structured compliance briefings for board-level and senior leadership audiences — translating Code obligations into commercially relevant business risk language.

Complaints Resolved. Launches Protected. Audits Passed.

“We received a PMCPA complaint on a Friday afternoon. Anzal was on a call by Monday morning, had reviewed all materials by Tuesday, and we had a clear response strategy before the deadline. The case was resolved without a breach finding. Having someone who understood both the process and the strategy made all the difference.”
— VP Regulatory Affairs, UK pharma company
“The pre-launch review flagged a structural issue with how we had classified our advisory board activity. If that had gone through, we would have been in breach of Chapter 18. That one engagement — one conversation before the materials were built — saved us considerably more than the cost of the advisory. It is the best return on a compliance investment I have seen.”
— Country Medical Director, specialty pharma affiliate

For Organisations That Need More Than a Policy Check

Strategic advisory is most valuable when the situation is genuinely complex, genuinely novel, or genuinely high-stakes. If the decision matters and the consequences of getting it wrong are significant, this is built for you.

Companies That Have Received a PMCPA Complaint

Immediate engagement from the point of complaint receipt — strategy, response drafting, and ongoing case management through to resolution.

UK Affiliates Preparing for an ABPI or MHRA Inspection

Pre-inspection gap analysis, mock audit, and prioritised remediation plan — with written documentation of compliance decision-making to present to inspectors.

Organisations Planning Novel Commercial Activities

Patient engagement, NIS studies, named patient programmes, or digital campaigns structured in a way the company has not done before — advisory before the activity begins.

Leadership Teams Needing Board-Level Compliance Briefings

Board members and senior leadership who need to understand the compliance implications of planned commercial strategies in clear, commercially relevant terms.

Companies Without a Senior In-House Compliance Function

Affiliates, emerging pharma companies, and smaller UK operations that need senior compliance expertise without the cost of a dedicated in-house hire.

Medical Affairs and Regulatory Teams Under Time Pressure

Situations where internal expertise exists but the timeline, novelty, or stakes of the decision require an experienced external perspective before proceeding.

Frequently Asked Questions

Can you manage a PMCPA complaint from start to finish?

Yes. Strategic advisory for PMCPA complaints covers the full process — from initial material review and response strategy through to drafting the formal written response, supporting any panel hearing process, and managing post-case undertakings. The level of involvement at each stage is discussed at the outset based on internal capacity and timeline.

Can you advise on novel activity types such as patient organisations or NIS studies?

Yes. Patient organisation interactions, non-interventional studies, disease awareness programmes, named patient schemes, and early access activities each have specific Code obligations distinct from standard HCP promotional activity. Strategic advice on how to structure these activities — to meet both the compliance requirements and the commercial objective — is a core part of this service.

What does a compliance audit preparation engagement look like?

The engagement begins with a process audit — review of current SOPs, governance documentation, materials approval records, and decision-making trails. A gap analysis is produced identifying areas of weakness relative to ABPI and MHRA audit expectations. A mock audit session follows, and a prioritised written report of recommendations is produced. The timeline is typically four to six weeks from engagement start to final report.

How is strategic advisory structured — retained, project-based, or ad hoc?

All three models are available and each has its place depending on your situation. Retained advisory suits organisations that need ongoing access to senior compliance expertise across multiple questions and projects. Project-based engagements are structured around a defined deliverable — a complaint, a launch, an audit. Ad hoc advisory provides access to expert guidance for specific questions without a formal engagement structure. The right model is discussed on the initial consultation call.

The Right Compliance Advice at the Right Time Changes Outcomes

Book a consultation to discuss your specific situation — whether it is a complaint, a launch, an inspection, or a question you have not been able to answer internally.

Request a Consultation →

Need instant answers?

19 specialist AI advisors — available 24/7

ABPI Code compliance, pharmacovigilance, GVP modules, signal detection and more. Ask anything, get structured referenced answers in seconds. From £9/month.

Explore AI Advisors → Try free →

Free Resource

⚖ Free Download: The PMCPA Complaint Defence Handbook

A step-by-step guide to navigating a PMCPA investigation — the timeline, what to do in the first 48 hours, how to build your defence, common mistakes, and when to appeal.

  • ✓  Instant access — no waiting
  • ✓  Printable PDF format
  • ✓  Written by a UK pharma compliance expert

Enter your details to get instant access:

Download: PMCPA Complaint Defence Handbook
⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week — free.

Subscribe Free
🎓 AQP Training